| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00036 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.00028 | 1 |